Navigation Links
Type of Tomato Product Determines Power Against Prostate Cancer
Date:5/29/2008

Compound produced during drying works with lycopene to protect against malignancies, study suggests

THURSDAY, May 29 (HealthDay News) -- Dried tomatoes, anyone?

A study in the June 1 issue of Cancer Research finds that the type of tomato product you eat may play a role in whether it can fight prostate cancer.

Specifically, an organic carbohydrate known as FruHis, which is produced when tomatoes are dehydrated, could be the secret ingredient.

But the study only looked at animals and, the authors warned, FruHis is not ready for the doctor's office or medicine cabinet just yet.

"This study was conducted in a rat model, and you cannot possibly draw any conclusions for people," said study author Valeri Mossine, a research assistant professor of biochemistry at the University of Missouri. "That's something we need to do next. But before you enter a study with humans, you have to prove that something works with animals. If it works, then you go on."

Several studies have pointed to a prostate cancer-fighting quality in tomatoes, but the exact mechanisms have been elusive.

In fact, the U.S. Food and Drug Administration laid out evidence or rather, a lack of it, behind a previous statement the agency had issued that tomato consumption is not linked to any reduction in risk of prostate tumors (or ovarian, stomach or pancreatic malignancies).

The November 2005 statement issued by the FDA contended that, "there is no credible evidence to support qualified health claims for lycopene, as a food ingredient, component or food, or as a dietary supplement, and reduced risk of any of the cancers in the petition."

But other experts, including the authors of the current study, are speculating that some other compound in tomatoes might interact with lycopene to produce the protective effect.

As the study points out, processing of edible plants (heating, grinding,
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Tomato Diet Cant Guarantee Prostate Health: Study
2. Fighting a Fungus That Thrives on Tomatoes
3. Dehydrated tomatoes show promise for preventing prostate cancer
4. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
5. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
6. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
7. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
8. End-to-End HR Performance Benchmarks: Metrics That Will Help Turn the HR Cost Center into a Productivity Driver
9. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
10. Drug Detection Kits Manufactured By IDenta Corp. Shown During French Television Broadcast (at TF1) - Product Aids French Police In Bust of 600 Kilograms Of Cocaine
11. Why Are Most Health & Wellness Products Doomed to Failure?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Type of Tomato Product Determines Power Against Prostate Cancer
Type of Tomato Product Determines Power Against Prostate Cancer
(Date:11/20/2008)... shot protects against infection that can cause me... , THURSDAY, Nov. 20 (HealthDay News) -- U.S. h...accine is leading them to monitor Hib infections, ...ess in young children. , Though the agency has ...rveillance was prompted by a disruption in the sup...
(Date:11/20/2008)...FORD, N.H., Nov. 20 Emerson Ecolog...ce International Distributors, Inc., also,known a...istributor of,vitamins and supplements to the pro...The combination of Emerson and TIDhealth creates t...e products and services in the high-growth,profes...
(Date:11/20/2008)...LAND, Calif., Nov. 20 Kaiser Perma...rn excellent, four-star ratings in the 2009,Editi...nia Office of the,Patient Advocate (OPA). , ...California OPA, also show,Kaiser Permanente North...he,highest scores overall in clinical quality amo...
(Date:11/20/2008)... Exstream Software by HP tod...rds, presented at the seventh annual North America..., LEXINGTON, Ky. (Business...ize customers that have used HP Exstream to make s...nce through the communications they send. Recipien...
Breaking Medicine News(10 mins):Health News:CDC Monitors Shortage of Hib Vaccine 2Health News:CDC Monitors Shortage of Hib Vaccine 3Health News:Emerson Ecologics Announces Acquisition of TIDhealth 2Health News:Emerson Ecologics Announces Acquisition of TIDhealth 3Health News:Kaiser Permanente Receives the Most Stars in California Office of Patient Advocate's Annual Quality Report Card 2Health News:Kaiser Permanente Receives the Most Stars in California Office of Patient Advocate's Annual Quality Report Card 3Health News: Exstream Software by HP Announces 2008 Visionary Award Winners : Customers Showcase Innovative Applications Created using the HP Exstream Enterprise Document Automation Solution 2Health News: Exstream Software by HP Announces 2008 Visionary Award Winners : Customers Showcase Innovative Applications Created using the HP Exstream Enterprise Document Automation Solution 3
... completed the second phase of testing of the vacc...ociated with 70% of cervical cancers and 90% of ge...ients were observed for 36 months and regularly ha...inal sampling for HPV DNA, pap testing and testing...
...ness often spreads from one family member to anoth...of alcohol based hand sanitizers are used more, th...testinal diseases from one family member to anothe...ccount the family belief and practices, members we...
... National Cancer Institute Maryland USA had found ...ture ageing// called Hutchinson-Gilford progeria s...n in the gene called LMNA. This gene is one of the...gy of mammals and reside in mammalian cell nucleus...
...lled Zingiber officinale, may be used as a medicat...t the women in the first trimester of pregnancy. T... benefits of ginger feels that taking ginger will ...t will also have no side effects on the fetus as w...
Other Medicine News:
(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
(Date:11/19/2008)...indings on critical enzyme,s regulation may hold k...f disorders , , MEMPHIS, Tenn., Nov. 19 /PR...ildren,s Research Hospital have gained new insight...horses called calpains. , , As the cell,s ... cellular processes, including the movement of cel...
(Date:11/19/2008)... -- Isogen, a contract development and,manufactur...ced the first,phase launch of its contract facili...y address the process, facility and capacity probl...y-niched, low-volume clinical and,early-stage com...ompanies can invest over $100 million and four yea...
(Date:11/18/2008)...rstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a spec...opment Company,and Sosei Group Corporation ("Sos...ional biopharmaceutical company, today announce th...re-clinical efficacy data for NSL-043/SD118.,This...europathic pain and has,successfully completed Ph...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Pennsylvania Insurance Department Announces New Web Page for Older Pennsylvanians 9057 1Pennsylvania Insurance Department Announces New Web Page for Older Pennsylvanians 9057 2ViroPharma Augments Senior Management 9054 1ViroPharma Augments Senior Management 9054 2ViroPharma Augments Senior Management 9054 3Pharmos Corporation Completes Initial Closing of Private Placement 2441 1Pharmos Corporation Completes Initial Closing of Private Placement 2441 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3
...stCall/ - Research,collaborators with Oncolytics B...r a poster presentation covering REOLYSIN(R),clini... Oncology,(ASCO) Annual Meeting, to be held June 1...of Oncolytics, U.K. Phase I systemic,administratio...a Phase I Study of,Wild-Type Oncolytic Reovirus Ad...
...1, 2007 - A therapeutic,vaccine developed by the G...es new hope for cancer patients. The results of a,...ented to an,international audience at the Annual C...ology (ASCO) in Chicago, USA. ASCO is the,most imp...ists,world-wide., The active substance VPM4001, an...
Other Medicine Technology:Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2
Non-mydriatic stereo fundus camera for glaucoma detection at early stage.
Recently updated with a high resolution 1640 x 1280 digital CCD the new Kowa Non Myd - digital achieves new levels of image quality, style and ease of use. Now supplied complete with Kowa's own compr
Nidek offers 3-Dx Digital stereo camera to provide a complete and comprehensive digital imaging platform.
Eye Q PRO is the optimum choice for ophthalmologists and clinicians specializing in advanced pathology and research.
Medicine Products: